Naturopathic Profession Regulations

Regulation
Registration
R-018-2022
Source
Unofficial consolidation PDF (justice.gov.nt.ca)
Under
Health and Social Services Professions Act

This is an unofficial reading copy parsed from the Department of Justice consolidation PDF above — itself an office consolidation, not an official statement of the law. The authoritative text is in the Revised Statutes of the Northwest Territories, 1988 and the annual Statutes volumes.

REGULATIONS

The Commissioner, on the recommendation of the Minister, under section 67 of the Health and Social Services Professions Act and every enabling power, makes the Naturopathic Profession Regulations.

Definitions

1.

In these regulations,

"accredited naturopathic school" means a naturopathic medical program accredited by the Council on Naturopathic Medical Education; (école de naturopathie agréée)

"compound" means to mix with one or more other ingredients; (préparer)

"Council on Naturopathic Medical Education" means the programmatic accrediting agency for naturopathic medical education programs that qualify graduates for naturopathic registration in Canada and the United States, recognized by the Canadian Association of Naturopathic Doctors, the American Association of Naturopathic Physicians, the North American Board of Naturopathic Examiners and the regulatory bodies that regulate the practice of naturopathic medicine in Canada and the United States; (Council on Naturopathic Medical Education)

"dispense", in respect of a drug, means to provide a drug under the authority of a prescription, but does not include the administration or sale of that drug; (délivrer)

"drug" means a drug set out in Schedule I, II or III of the National Drug Schedules established by the National Association of Pharmacy Regulatory Authorities, as amended from time to time; (drogue)

"expanded register" means the expanded register of the Naturopathic Profession Register referred to in paragraph 2(1)(b); (registre étendu)

"general register" means the general register of the Naturopathic Profession Register referred to in paragraph 2(1)(a); (registre général) "Schedule I drug" means a drug set out in Schedule I of the National Drug Schedules referred to in the definition "drug"; (drogue mentionnée à l’Annexe I)

"substance" means anything, other than a drug, that is publicly available and which may include botanical tinctures, botanical powders or loose herbs, extracts, base creams, salves and ointments, homeopathic remedies, vitamins, minerals and amino acids. (substance)

Register

2.

(1) The Naturopathic Profession Register is established and is divided into the following categories:

(a) general register;

(b) expanded register.

(2) The Naturopathic Profession Register may be maintained in an electronic format.

(3) Any person may, on request and during regular office hours, inspect the Naturopathic Profession Register.

Registration and Licensing

3.

(1) For the purpose of section 10 of the Act, a person is eligible to be registered on the general register if the person

(a) has successfully completed a program of studies in naturopathic medicine offered by an accredited naturopathic school;

(b) has successfully passed

(i) the Naturopathic Physicians Licensing Examinations, Parts I and II, set by the North American Board of Naturopathic Examiners, or

(ii) the Clinical Sciences Examination and the Biomedical Examination, both set by the College of Naturopaths of Ontario;

(c) has successfully passed

(i) the oral and practical examinations set by the College of Naturopathic Physicians of British Columbia, or

(ii) the Ontario Clinical (Practical) Examinations in Naturopathic Manipulation, Acupuncture and Physical Examination/ Instrumentation, set by the College of Naturopaths of Ontario;

(d) meets one of the following criteria:

(i) within the two years immediately preceding the date the Registrar receives the person’s application, has completed the requirements in paragraphs (a), (b) and (c),

(ii) within the three years immediately preceding the date the Registrar receives the person’s application, has provided 1200 hours of professional services as a naturopath while registered as a member in good standing on the equivalent of the general or expanded register in a province or another territory or in another jurisdiction recognized by the Registrar;

(e) holds professional liability insurance, issued by a company authorized to carry on business in Canada, in at least the minimum amount approved by the Minister; and

(f) is authorized to work in Canada.

(2) For the purpose of section 10 of the Act, a person is eligible to be registered on the expanded register with respect to one or more of the activities listed in subsection 6(2) if the person

(a) meets the eligibility requirements for the general register set out in subsection (1); and

(b) has successfully completed accredited training to perform the activities for which they are applying for registration.

4.

(1) An application by a person for registration on the general register and for the issuance of a licence under section 11 of the Act must include

(a) a written statement regarding

(i) the applicant’s intention to provide the services of the profession of naturopathic medicine in the Northwest Territories, and the location where those services will be provided, and

(ii) whether the applicant is entitled to practice naturopathic medicine in a province or another territory, and whether the applicant will provide those services in that province or territory;

(b) the results of the following checks obtained from the Royal Canadian Mounted Police and dated not more than six months before the date the application is submitted:

(i) criminal record check,

(ii) vulnerable sector check; and

(c) evidence satisfactory to the Registrar that the applicant meets the eligibility requirements set out in subsection 3(1).

(2) An application by a person for registration on the expanded register and for the issuance of a licence under section 11 of the Act must include

(a) the information and evidence set out in paragraphs (1)(a) to (c); and

(b) evidence of successful completion of the training referred to in paragraph 3(2)(b).

R-107-2024,s.2.

5.

For the purpose of subsections 11(3), 14(4), 17(5) and 18(5) of the Act, the Registrar shall review an application within 60 days of receipt of all information and documentation required by the Registrar under the Act and these regulations as a part of that review.

Scope of Practice

6.

(1) A registered member on the general or expanded register may, in the practice of naturopathic medicine, in accordance with their registration and licence and subject to any conditions imposed on the member’s licence,

(a) insert or remove instruments, devices or fingers

(i) beyond the cartilaginous portion of the ear canal,

(ii) beyond the point in the nasal passages where they normally narrow,

(iii) beyond the opening of the urethra for the purpose of obtaining diagnostic samples,

(iv) beyond the labia majora, but not beyond the cervix, for the purpose of examining the cervix, performing Pap smears and obtaining diagnostic samples, and

(v) beyond the anal verge, but not beyond the rectal-sigmoidal junction, for the purpose of a rectal or prostate exam;

(b) communicate a diagnosis to a patient that identifies, through an assessment using naturopathic techniques, a disease, disorder or dysfunction as the cause of the patient’s symptoms;

(c) perform a procedure on the tissue below the dermis or below the surface of the mucous membrane for the purpose of venipuncture;

(d) order and perform laboratory and non-laboratory tests;

(e) collect and interpret the results of laboratory and non-laboratory tests;

(f) administer a substance by inhalation; and

(g) compound and sell a substance.

(2) A registered member on the expanded register may, in addition to those activities listed in subsection (1), in accordance with their registration and licence and subject to any conditions imposed on that licence, do one or more of the following:

(a) perform surgery that is minor and that does not include sedation, general anesthesia or respiratory assistance;

(b) use electricity, in the course of performing surgery under paragraph (a), for the purpose of destroying tissue;

(c) cut a body tissue, administer anything by an invasive procedure on body tissue or perform an invasive procedure on body tissue below the dermis or the mucous membrane for the purpose of

(i) needle acupuncture, or

(ii) administering intravenous ozone, chelation therapy, prolotherapy or supplemental vitamins and minerals;

(d) prescribe, dispense, compound or administer a Schedule I drug, other than a drug set out in Schedule A;

(e) use a deliberate, brief and fast thrust to move the joints of the spine beyond the normal range but within the anatomical range of motion;

(f) insert or remove instruments, devices or fingers

(i) beyond the labia majora for the purpose of performing vaginal ozone therapy, or

(ii) beyond the anal verge for the purpose of performing hydro therapy, rectal ozone therapy or the Keesey technique for the reduction of hemorrhoids;

(g) perform hyperbaric oxygen therapy.

(3) A registered member on the general register shall not perform any of the activities listed in subsection (2).

(4) Notwithstanding any authorization to perform activities listed in subsections (1) and (2), registered members shall restrict themselves to performing those activities that they are competent to perform and to those that are appropriate to the member’s area of practice and the procedure being performed.

Licence Expiry and Renewal

7.

A licence issued to a registered member expires on December 31 of each year.

8.

An application by a registered member for renewal under section 14 of the Act must include

(a) a written statement regarding

(i) the member’s intention to provide the services of the profession of naturopathic medicine in the Northwest Territories, and the location where those services will be provided,

(ii) whether the member is entitled to practice naturopathic medicine in a province or another territory, and whether the member will provide those services in that province or territory,

(iii) whether the member was charged with or convicted of an offence under the Criminal Code (Canada) within the past year, and

(iv) whether the member was subject to a disciplinary complaint, investigation or hearing in any other jurisdiction within the past year;

(b) a written statement that the member has complied with the continuing competency requirements set out in section 9; and

(c) proof of professional liability insurance, issued by a company authorized to carry on business in Canada, in at least the minimum amount approved by the Minister.

Continuing Competency

9.

(1) In this section, "continuing competency activity" means any of the following which contribute to a registered member’s knowledge or skill in the practice of naturopathic medicine:

(a) participation in courses, workshops, seminars or discussion groups, either as a presenter or facilitator, including time spent preparing to present or facilitate, or as an attendee;

(b) self-directed learning or study, including reading professional journals or other reference sources and publishing research;

(c) participation in Indigenous cultural awareness training.

(2) For the purpose of section 13 of the Act, a registered member on the general or expanded register shall complete, in each two-year reporting period beginning on November 1 of each even-numbered year and ending on October 31 of the following even-numbered year,

(a) 40 hours of continuing competency activities; and

(b) Basic Life Support or CPR for Health Care Providers (with AED) training.

(3) For the purpose of section 13 of the Act, a registered member on the expanded register shall complete, in addition to the requirements set out in subsection (2),

(a) in each two-year reporting period as set out in subsection (2), four hours of continuing competency activities related to each expanded scope activity in respect of which the member is registered and licenced; and

(b) in each four-year reporting period beginning on November 1 of every second even-numbered year and ending on October 31 of the second even-numbered year following the start of the reporting period, a medical emergency refresher course approved by the Minister.

(4) Notwithstanding subsections (2) and (3), if at the time of an application for renewal under section 14 of the Act, a member has been registered for less than two years, the Registrar may waive all or part of the requirements set out in this section.

(5) Notwithstanding paragraph (3)(b), if at the time of an application for renewal under section 14 of the Act, a member has been registered for less than four years, the Registrar may waive the requirement set out in that paragraph. R-072-2022,s.2.

10.

(1) A registered member shall record all continuing competency activities completed by the member in a format approved by the Minister.

(2) A registered member shall retain the continuing competency record required under subsection (1) for a minimum of five years.

Standards, Guidelines and Code of Ethics

11.

(1) In this section,

"Code of Ethics" means the Code of Ethics published by the College of Naturopathic Doctors of Alberta; (code de déontologie)

"Northwest Territories Guidelines for Naturopathic Doctors" means the Northwest Territories Guidelines for Naturopathic Doctors, published by the Department of Health and Social Services; (Lignes directrices des docteurs en naturopathie des Territoires du Nord-Ouest)

"Northwest Territories Standards of Practice for Naturopathic Doctors" means the Northwest Territories Standards of Practice for Naturopathic Doctors, published by the Department of Health and Social Services. (Normes de pratique des docteurs en naturopathie des Territoires du Nord-Ouest)

(2) The Northwest Territories Guidelines for Naturopathic Doctors and the Northwest Territories Standards of Practice for Naturopathic Doctors are adopted as amended from time to time.

(3) Subject to subsection (4), the Code of Ethics is adopted, as amended from time to time, as the code of ethics governing registered members on the general or expanded register.

(4) The Code of Ethics is adopted with any modifications the circumstances require, and a reference in the Code to

(a) "Alberta" shall be read as "Northwest Territories";

(b) "College" shall be read as "Standards of Practice for Naturopathic Practitioners"; and

(c) "CNDA Council" shall be read as "Government of the Northwest Territories".

(5) A registered member engaged in the practice of naturopathic medicine and providing the services of that profession shall do so in accordance with

(a) the Code of Ethics;

(b) the Northwest Territories Guidelines for Naturopathic Doctors;

(c) the Northwest Territories Standards of Practice for Naturopathic Doctors; and

(d) generally accepted professional standards and procedures.

Unprofessional Conduct

12.

For the purpose of subsection 22(3) of the Act, unprofessional conduct includes providing a service that a registered member is not, at the time the service is provided, authorized under the Act and these regulations to provide.

Initial Review of Complaint

13.

For the purpose of subsection 26(1) of the Act, the Complaints Officer shall complete their review and inquiry within 60 days of receipt of all information and documentation required by the Complaints Officer as a part of that review and inquiry.

Titles

14.

(1) The use of the following titles and their abbreviations is reserved to registered members:

(a) Naturopathic Doctor and its initials N.D.;

(b) Naturopathic Practitioner;

(c) Naturopathic Physician;

(d) Naturopath;

(e) Doctor of Naturopathic Medicine and its initials N.M.D.;

(f) Doctor of Naturopathy.

(2) Subsection (1) does not apply for a period of six months following the date on which these regulations come into force.

Fees

15.

The fees payable under the Act and these regulations are set out in Schedule B.

Coming into Force

16.

These regulations come into force on the day on which section 5 of the Health and Social Services Professions Act, SNWT 2015, c.4 comes into force.

SCHEDULE A

(paragraph 6(2)(d))

Excluded Schedule I Drugs

Part 1. Acute Perinatal Care Agents

1. Beractant

2. Colfosceril or its derivatives

3. Nitric Oxide

4. Poractant Alfa

Part 2. Agents used for Emergency Purposes Only

1. Adenosine or its salts

2. Amiodarone or its salts or derivatives

3. Atropine or its salts

4. Dopamine or its salts

5. Procainamide or its salts

6. Propafenone or its salts

7. Verapamil or its salts

Part 3. Antiarrhythmic Agents

1. Bretylium tosylate

2. Disopyramide or its salts

3. Esmolol or its salts

4. Flecainide or its salts

5. Ibutilide or its salts or derivatives

6. Isoproterenol or its salts

7. Methoxamine or its salts

8. Mexiletine or its salts

9. Procainamide or its salts

10. Propafenone or its salts

11. Quinidine salts

12. Sotalol or its salts

13. Tocainide or its salts

14. Verapamil or its salts

Part 4. Antibiotics with narrow therapeutic index

1. Amikacin or its salts or derivatives

2. Amphotericin B or its salts or derivatives

3. Apramycin or its salts or derivatives

4. Atovaquone or its salts or derivatives

5. Aztreonam or its salts or derivatives

6. Bacitracin or its salts or derivatives, except when used for intravenous therapy

7. Candicidin or its salts or derivatives

8. Carbapenem or its salts or derivatives

9. Carbomycin or its salts or derivatives

10. Caspofungin or its salts or derivatives

11. Cephalosporin or its salts or derivatives

12. Cilastatin or its salts or derivatives

13. Colistin or its salts or derivatives

14. Dalfopristin or its salts or derivatives

15. Dihydrostreptomycin or its salts or derivatives

16. Enrofloxacin or its salts or derivatives

17. Gentamicin when used for intravenous therapy

18. Grepafloxacin or its salts or derivatives

19. Marbofloxacin or its salts or derivatives

20. Mecillinam or its salts or derivatives

21. Mezlocillin or its salts or derivatives

22. Quinupristin or its salts or derivatives

23. Streptomycin or its salts or derivatives

24. Tazobactam or its salts or derivatives

25. Tobramycin or its salts or derivatives when used for intravenous therapy

26. Trovafloxacin or its salts or derivatives

27. Vancomycin or its salts or derivatives

28. Virginiamycin or its salts or derivatives

29. Voriconazole or its salts or derivatives

Part 5. Anticonvulsants

1. Carbamazepine, except when used for pain management

2. Gabapentin or its salts or derivatives, except when used for pain management

3. Lamotrigine or its salts

4. Methoin (mephenytoin) or its salts

5. Oxcarbazepine

6. Phenacemide

7. Pregabalin or its salts or derivatives, except when used for pain management

8. Primidone

9. Topiramate

10. Trimethadione

11. Valproic Acid or its salts

12. Vigabatrin or its salts or derivatives

Part 6. Antineoplastic Agents

1. 5-Fluorouracil when used for intravenous therapy

2. Apalutamide or its salts

3. Cyproterone Acetate

4. Darolutamide

5. Flutamide

6. Hydroxyurea

7. Vinblastine or its salts

8. Vincristine or its salts

9. Vindesine or its salts

10. Vinorelbine or its salts Part 7. Antiparkinson Agents

1. Benserazide or its salts

2. Biperiden or its salts

3. Entacapone

4. Safinamide or its salts or derivatives

5. Tolcapone

Part 8. Antipsychotic Agents

1. Acepromazine or its salts

2. Butaperazine or its salts

3. Chlorpromazine or its salts

4. Chlorprothixene or its salts

5. Clozapine or its salts

6. Flupenthixol or its salts or derivatives

7. Fluphenazine or its salts

8. Haloperidol

9. Lithium or its salts in doses >150mg equivalent of lithium carbonate

10. Loxapine or its salts

11. Mesoridazine or its salts

12. Methotrimeprazine or its salts

13. Olanzapine or its salts

14. Pericyazine or its salts

15. Perphenazine or its salts

16. Pimozide

17. Pipotiazine or its salts

18. Prochlorperazine or its salts

19. Promazine or its salts

20. Quetiapine or its salts

21. Remoxipride or its salts

22. Risperidone or its salts

23. Tetrabenazine or its salts

24. Thiethylperazine or its salts

25. Thioridazine or its salts

26. Thiothixene or its salts

27. Trifluoperazine or its salts

28. Triflupromazine or its salts

29. Trimeprazine or its salts

30. Zuclopenthixol or its salts or derivatives

Part 9. Antitubercular agents used for other infections

1. Isoniazid Part 10. Antiviral Agents

1. Foscarnet Sodium

2. Ganciclovir or its salts

3. Idoxuridine

4. Ribavirin

5. Valganciclovir or its salts or derivatives

Part 11. Botulinum Toxins

1. Botulinum Toxin Type A, except when used for pain management

2. Botulinum Toxin Type B, except when used for pain management

Part 12. Disease Modifying Agents

1. Denosumab

2. Azathioprine, except when used for continuation therapy

3. Methotrexate, except when used for continuation therapy

4. Penicillamine, except when used for chelation therapy

Part 13. Emergency Medicine Agents

1. Amrinone or its salts

2. Bosentan or its salts or derivatives

3. Digoxin Immune Fab

4. Dobutamine or its salts

5. Drotrecogin

6. Fomepizole or its salts

7. Hetastarch or its derivatives

8. Leucovorin or its salts

9. Milrinone or its salts

10. Physostigmine Salicylate, except in preparations for oral or topical use

11. Sodium Nitroprusside or its salts or derivatives

Part 14. Endocrine Agents/Endocrine Diagnostic Agents

1. Gonadorelin or its salts

2. Mepacrine or its salts

3. Metyrapone or its salts

4. Nafarelin or its salts or derivatives

5. Pegvisomant

6. Protirelin

7. Thyrotropin Alfa

8. Quinagolide or its salts

9. Sermorelin or its salts

10. Terlipressin or its salts

11. Triiodothyropropionic Acid

12. Trilostane

Part 15. Iron Derivatives

1. Iron when used for intravenous therapy

Part 16. Obstetrical Agents

1. Carbetocin or its salts

2. Oxytocin

3. Ritodrine or its salts

Part 17. Ophthalmic Agents

1. Bimatoprost, except when used for the treatment of hypotrichosis of the eyelid to a maximum strength of 0.03% w/v

2. Brimonidine or its salts

3. Carbachol

4. Dexamethasone, except for ophthalmic use

5. Dipivefrin or its salts

6. Dorzolamide or its salts

7. Ecothiophate or its salts

8. Latanoprostene Bunod or its salts or derivatives

9. Levobunolol or its salts

10. Methazolamide or its salts

11. Pegaptanib

12. Pilocarpine or its salts

13. Prednisolone except for ophthalmic use

14. Trifluridine

15. Unoprostone or its salts

16. Verteporfin

Part 18. Thrombolytic, Hemostatic and Anti-platelet Agents

1. Alteplase or its salts or derivatives

2. Aminocaproic acid

3. Aprotinin

4. Argatroban or its salts or derivatives

5. Bivalirudin

6. Danaparoid or its salts or derivatives

7. Enoxaparin or its salts

8. Eptifibatide or its salts

9. Reviparin or its salts

10. Streptokinase / streptodornase

11. Tenecteplase or its salts or derivatives

12. Tirofiban or its salts or derivatives

13. Tranexamic acid Part 19. Other Excluded Schedule I Drugs

1. Acetohexamide

2. Adalimumab

3. Adefovir or its salts

4. Agalsidase Alfa

5. Aldesleukin

6. Alemtuzumab

7. Alkyl Nitrites

8. Alprazolam

9. Altretamine

10. Amifostine or its salts

11. Aminoglutethimide

12. Aminopterin or its salts

13. Aminopyrine or its derivatives

14. Amprenavir or its salts or derivatives

15. Amsacrine or its salts

16. Anagrelide or its salts

17. Anakinra or its salts or derivatives

18. Anastrozole

19. Ancestim

20. Anileridine

21. Anti-thymocyte Globulin

22. Atazanavir or its salts

23. Atracurium Besilate

24. Auranofin

25. Aurothioglucose

26. Basiliximab

27. Bevacizumab

28. Bicalutamide

29. Bleomycin

30. Bortezomib

31. Bromazepam or its salts

32. Buprenorphine

33. Buserelin or its salts

34. Busulfan

35. Butalbital

36. Butorphanol

37. Cabergoline or its salts

38. Capecitabine or its salts or derivatives

39. Carboplatin

40. Carmustine

41. Cetrorelix or its salts

42. Cetuximab

43. Chlorambucil or its salts or derivatives

44. Chlordiazepoxide or its salts

45. Chlorisondamine or its salts

46. Choriogonadotropin Alfa

47. Cinacalcet or its salts

48. Cisplatin

49. Cladribine or its salts

50. Clobazam or its salts

51. Clonazepam or its salts

52. Clorazepic acid or its salts

53. Codeine, when prescribed as a single entity or when included in a preparation containing more than 8 mg per dosage unit

54. Cyclophosphamide

55. Cycloserine

56. Cyclosporine

57. Cytarabine or its salts

58. Dacarbazine

59. Daclizumab

60. Dactinomycin

61. Daunorubicin or its salts

62. Delavirdine or its salts

63. Desflurane

64. Dexrazoxane or its salts

65. Diazepam or its salts

66. Didanosine or its salts or derivatives

67. Diethylstilbestrol or its derivatives

68. Dihydrotachysterol

69. Dinoprostone or its salts or derivatives

70. Docetaxel or its derivatives

71. Doxacurium chloride

72. Doxercalciferol or its derivatives

73. Doxorubicin or its salts

74. Droperidol or its salts

75. Edrophonium chloride

76. Efavirenz

77. Emtricitabine

78. Enflurane

79. Enfuvirtide

80. Epirubicine or its salts

81. Erythropoietin

82. Estazolam or its salts

83. Estramustine or its salts

84. Etanercept

85. Ethambutol or its salts

86. Ethchlorvynol

87. Ethionamide or its salts

88. Ethoheptazine or its salts

89. Etoposide or its derivatives

90. Exemestane

91. Fenfluramine or its salts

92. Fentanyl

93. Filgrastim

94. Flucytosine

95. Fludarabine or its salts or derivatives

96. Flumazenil

97. Fluorouracil or its derivatives, except when used for intravenous therapy

98. Flurazepam or its salts

99. Flutamide

100. Follicle stimulating hormone

101. Formestane or its salts or derivatives

102. Fulvestrant

103. Gallamine triethiodide

104. Ganirelix or its salts or derivatives

105. Gefitinib

106. Gemcitabine or its salts

107. Glatiramer or its salts

108. Gold or its salts

109. Goserelin or its salts

110. Halazepam or its salt

111. Halofantrine or its salts

112. Halothane

113. Hydrocodone

114. Hydromorphone

115. Hydroxychloroquine or its salts

116. Idarubicin or its salts

117. Ifosfamide

118. Imatinib or its salts

119. Imiglucerase

120. Indinavir or its salts

121. Infliximab

122. Interferon

123. Iproniazid or its salts

124. Irinotecan or its salts

125. Isoflurane

126. Ivermectin or its derivatives

127. Kanamycin or its salts or derivatives

128. Ketamine or its salts

129. Ketazolam or its salts

130. Lamivudine or its salts

131. Laronidase

132. L-Asparaginase

133. Leflunomide or its salts

134. Letrozole

135. Leuprolide or its salts

136. Levallorphane or its salts

137. Levamisole or its salts

138. Levorphanol

139. Lincomycin or its salts or derivatives

140. Linezolid or its salts

141. Lomefloxacin or its salts

142. Lomustine

143. Lopinavir

144. Loracarbef or its salts or derivatives

145. Lorazepam or its salts

146. Mazindol or its salts

147. Mecamylamine or its salts

148. Mechlorethamine or its salts

149. Melphalan

150. Menotropins

151. Meperidine (pethidine)

152. Mercaptopurine

153. Meropenem or its salts or derivatives

154. Mesna

155. Metaraminol Bitartrate

156. Methadone

157. Methaqualone

158. Midazolam or its salts

159. Midodrine or its salts

160. Miglustat

161. Mitomycin or its salts

162. Mitotane

163. Mitoxantrone or its salts

164. Mivacurium Chloride

165. Molgramostim in amounts greater than 8 mg per dosage unit

166. Morphine

167. Muromonab-CD3

168. Mycophenolic Acid or its salts or derivatives

169. Nalmefene or its salts

170. Nelfinavir or its salts

171. Neostigmine salts

172. Netilmicin or its salts or derivatives

173. Nevirapine or its salts

174. Nikethamide

175. Nilutamide

176. Nitrazepam or its salts

177. Normethadone

178. Octreotide

179. Oxazepam or its salts

180. Oxycodone

181. Paclitaxel or its derivatives

182. Palivizumab

183. Pamidronic acid or its salts

184. Pancuronium or its salts

185. Pegfilgrastim

186. Pemetrexed or its salts

187. Pentamidine or its salts

188. Pentazocine

189. Pentolinium Tartrate

190. Pentostatin or its salts

191. Perflutren

192. Phentolamine or its salts

193. Pipobroman

194. Porfimer or its salts

195. Pralidoxime or its salts

196. Prazepam or its salts

197. Prodilidine or its salts

198. Propofol

199. Propoxyphene

200. Pyrazinamide

201. Pyridostigmine Bromide

202. Raltitrexed or its salts or derivatives

203. Rasburicase

204. Rifabutin or its salts

205. Riluzole or its salts

206. Ritonavir

207. Rituximab

208. Rocuronium Bromide

209. Rofecoxib

210. Saquinavir or its salts or derivatives

211. Sargramostim

212. Sevelamer Hydrochloride

213. Sirolimus or its derivatives

214. Sodium Aurothiomalate

215. Stavudine

216. Streptozocin

217. Succinylcholine or its salts

218. Sufentanil

219. Suxamethonium Chloride

220. Tacrolimus or its derivatives

221. Tegafur or its salts

222. Temazepam or its salts

223. Temozolomide or its salts

224. Teniposide

225. Tenofovir or its salts or derivatives

226. Thalidomide

227. Thiocarlide

228. Thioguanine

229. Thiotepa

230. Tiludronic Acid or its salts

231. Tipranavir or its salts

232. Topotecan or its salts

233. Toremifene or its salts

234. Trastuzumab

235. Treosulfan

236. Treprostinil or its salts

237. Tretamine

238. Triazolam or its salts

239. Trimethaphan Camsylate

240. Trimetrexate or its salts

241. Troglitazone

242. Tubocurarine or its salts

243. Valrubicin or its derivatives

244. Vecuronium Bromide

245. Viomycin or its salts or derivatives

246. Zalcitabine or its salts

247. Zidovudine

248. Zoledronic Acid or its salts or derivatives

SCHEDULE B (section 14)

Fees

1. Designation Application fee................................................................ $0

2. Initial Application, Registration and Licence fee - General Register.............................. $2,343

3. Initial Application, Registration and Licence fee - Expanded Register ............................ $2,443

4. Fee for Additional Expanded Register Activity............................................... $100

5. Licence Renewal fee - General and Expanded Register........................................ $2,068

6. Late fee for Licence Renewal ............................................................ $385

7. Reinstatement fee - General Register...................................................... $2,068

8. Reinstatement fee - Expanded Register .................................................... $2,343

9. Fee for Certificate of Standing............................................................. $26

R-089-2025,s.2.